Navigation Links
Halleland Health Consulting Hires New Director of Lifescience Business Development Peter T. Bianco
Date:5/1/2008

Bianco's strategic business experience brings depth to specialized

consulting group

MINNEAPOLIS, May 1 /PRNewswire/ -- Halleland Health Consulting, a wholly owned subsidiary of Minneapolis law firm Halleland Lewis Nilan & Johnson, P.A., announces the hire of Peter T. Bianco as Director of Lifescience Business Development. In addition to coaching bioscience businesses through start-up and growth challenges with the consulting subsidiary, Bianco's work will also be integrated with the law firm's health care and business practice areas.

"Bianco's expertise around medical technologies, services, and infrastructure make him an exceptional addition to our accomplished health consulting team," said Brian Johnson, president of Halleland Lewis Nilan & Johnson. "His strategic and hands-on experience in the bioscience industry brings another level of clarity and competency to our clients."

Bianco comes to the firm after serving as the president of Bioscience Business Development, LLC, where he provided strategic business development for early-stage and large businesses focused on a variety of medical technologies and related services with specific focus on successful early stage lifescience technology commercialization and the financial and physical infrastructure to support it.

Prior to that, he served as the chief executive officer of University Enterprise Laboratories in St. Paul, Minn. His previous experience also includes over ten years in Orthopedic product management, product development engineering and medical device marketing for medical device giant Johnson & Johnson Professional, Inc. and Dow Corning Wright. He began his career in Orthopedic Biomechanics Research at the Mayo Clinic in Rochester, Minn. and Hennepin County Medical Center in Minneapolis, Minn.

He is a founder and board member of Suffolk University's Center for Innovation and Change Leadership (CICL) in Boston, Mass. where he earned his MBA. He received his bachelor's degree in physiology from the University of Minnesota. He serves as vice chairman of the board of directors for the Midwest Orthopedic Research Foundation (MORF) and is a member of the business advisory board for the Regulatory and Clinical Research Institute (RCRI) and Orthopedic Research Society (ORS). Peter currently resides in St. Paul, Minn. with his family.

About Halleland Health Consulting

Halleland Health Consulting, a wholly owned subsidiary of Halleland Lewis Nilan & Johnson, P.A., brings experienced health care professionals with operational, policy and business expertise together with attorneys who specialize in an array of health care and regulatory issues. The integrated team of attorneys, health care providers, public health professionals and health care operations and policy experts helps to guide clients through the maze of legal and business complexities, yielding fresh solutions to contemporary health care problems. Founded in 1996, Halleland Lewis Nilan & Johnson has built its reputation by putting clients first and building a practice centered on values - thus defining the next generation of law firm. In addition to health care, the firm has practice areas in business law and intellectual property litigation, commercial litigation, labor and employment and product liability/mass tort litigation.


'/>"/>
SOURCE Halleland Health Consulting
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Halleland Health Consulting Assists PBMs in Achieving URAC Accreditation for Pharmacy Benefit Management
2. Penn study finds pro-death proteins required to regulate healthy immune function
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Air pollution linked to cardiovascular risk indices in healthy young adults
5. More proof needed of safety and quality of electronic personal health records
6. Health care incentive model offers collaborative approach
7. Loneliness is bad for your health
8. Mailman School of Public Health study examines link between racial discrimination and substance use
9. Green Tea May Brew Up Healthier Skin
10. For Health Info, Women Often Turn to the Web
11. Record Number of Americans Lack Health Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ... committed to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne ... (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced today. , ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... attempts to compare student test score performance for the 2015-16 school year across ... state’s voucher programs. Though it highlights important patterns in student test score performance, ...
(Date:4/25/2017)... Las Vegas, NV (PRWEB) , ... April 25, ... ... teeth can now choose a modern procedure that achieves results in a fraction ... orthodontist in Las Vegas, NV, with Significance Dental Specialists, now offers this ...
(Date:4/25/2017)... ... , ... Back Pain Centers of America (BPC), which connects people ... their area, announces the launch of a new and proprietary customer relationship management (CRM) ... reputable physicians to help them with back or neck pain and helps to match ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... analytics to its patient care management module. Using this new feature, sleep physicians ... has been initiated on continuous positive airway pressure (CPAP), oral, or other forms ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
Breaking Medicine Technology: